Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bruker Corporation - Common Stock (NQ:BRKR)

41.90 +0.70 (+1.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bruker Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bruker Announces Public Offering of Common Stock
From Bruker Corporation
Via Business Wire
Access Reminder for Bruker Investor Webinar on May 17, 2024
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker Corporation to Host Investor Webinar on May 17, 2024
From Bruker Corporation
Via Business Wire
German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Bruker
From Bruker Corporation
Via Business Wire
Bruker Completes Asset Acquisition of NanoString Business
From Bruker Corporation
Via Business Wire
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
From Bruker Corporation
Via Business Wire
Bruker Reports First Quarter 2024 Financial Results
From Bruker Corporation
Via Business Wire
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker to Acquire the NanoString Business in an Asset Deal
From Bruker Corporation
Via Business Wire
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
From Bruker Corporation
Via Business Wire
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
From Bruker Corporation
Via Business Wire
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
From Biognosys AG
Via GlobeNewswire
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
From Bruker Corporation
Via Business Wire
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
From Bruker Corporation
Via Business Wire
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
From Bruker Corporation
Via Business Wire
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at Upcoming Investor Conferences
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
From Bruker Corporation
Via Business Wire
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
From Bruker Corporation
Via Business Wire
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
From Bruker Corporation
Via Business Wire
Bruker Announces Agreement to Acquire Chemspeed
From Bruker Corporation
Via Business Wire
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
From Bruker Corporation
Via Business Wire
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
From Biognosys AG
Via GlobeNewswire
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Bruker Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.